AU577781B2 - Lung imaging with radiolabelled agents - Google Patents

Lung imaging with radiolabelled agents

Info

Publication number
AU577781B2
AU577781B2 AU27248/84A AU2724884A AU577781B2 AU 577781 B2 AU577781 B2 AU 577781B2 AU 27248/84 A AU27248/84 A AU 27248/84A AU 2724884 A AU2724884 A AU 2724884A AU 577781 B2 AU577781 B2 AU 577781B2
Authority
AU
Australia
Prior art keywords
lung imaging
radiolabelled agents
radiolabelled
agents
lung
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU27248/84A
Other versions
AU2724884A (en
Inventor
Mark Philip Best
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to AU27248/84A priority Critical patent/AU577781B2/en
Publication of AU2724884A publication Critical patent/AU2724884A/en
Application granted granted Critical
Publication of AU577781B2 publication Critical patent/AU577781B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1206Administration of radioactive gases, aerosols or breath tests
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1024Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against hormones, hormone-releasing or hormone-inhibiting factors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1054Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from lung
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical & Material Sciences (AREA)
  • Optics & Photonics (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Atmospheric Sciences (AREA)
  • Dispersion Chemistry (AREA)
AU27248/84A 1983-04-28 1984-04-24 Lung imaging with radiolabelled agents Ceased AU577781B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU27248/84A AU577781B2 (en) 1983-04-28 1984-04-24 Lung imaging with radiolabelled agents

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPF909883 1983-04-28
AUPF9098 1983-04-28
AU27248/84A AU577781B2 (en) 1983-04-28 1984-04-24 Lung imaging with radiolabelled agents

Publications (2)

Publication Number Publication Date
AU2724884A AU2724884A (en) 1984-11-01
AU577781B2 true AU577781B2 (en) 1988-10-06

Family

ID=25620210

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27248/84A Ceased AU577781B2 (en) 1983-04-28 1984-04-24 Lung imaging with radiolabelled agents

Country Status (1)

Country Link
AU (1) AU577781B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996014849A1 (en) * 1994-11-11 1996-05-23 HAIDER, Angelika Use of aminoglycosides to diagnose blood-air barrier disorders

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4280991A (en) * 1977-07-29 1981-07-28 Capital Territory Health Commission Diagnostic compositions
AU556548B2 (en) * 1980-03-03 1986-11-06 Milton David Goldenberg Tumor localization and therapy with labeled antibodies and antibody fragments specific to tumor-associated markers
AU568138B2 (en) * 1983-07-29 1987-12-17 Milton David Goldenberg Method for enhancing target specificity of antibody localization + clearance of non-target diagnostic and therapeutic principles

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4280991A (en) * 1977-07-29 1981-07-28 Capital Territory Health Commission Diagnostic compositions
AU556548B2 (en) * 1980-03-03 1986-11-06 Milton David Goldenberg Tumor localization and therapy with labeled antibodies and antibody fragments specific to tumor-associated markers
AU568138B2 (en) * 1983-07-29 1987-12-17 Milton David Goldenberg Method for enhancing target specificity of antibody localization + clearance of non-target diagnostic and therapeutic principles

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996014849A1 (en) * 1994-11-11 1996-05-23 HAIDER, Angelika Use of aminoglycosides to diagnose blood-air barrier disorders

Also Published As

Publication number Publication date
AU2724884A (en) 1984-11-01

Similar Documents

Publication Publication Date Title
AU557426B2 (en) Imaging system
AU570037B2 (en) N-phenylsulphonyl - n'pyrimidinyl - and - triazinyl-ureas
AU558490B2 (en) Imaging system
AU590511B2 (en) Bioluminescent immunoassays
AU9165482A (en) X-ray contrast agents
AU564375B2 (en) Spirometer
AU2780784A (en) Antisnoring agent
AU555197B2 (en) Polyamide blends
AU570717B2 (en) Cricket ball
AU564307B2 (en) Polyetherimide-polyimide blends
AU1550483A (en) Polyetherimide-polyimide blends
AU1193383A (en) Polyethermide-polyester blends
AU562257B2 (en) Radiographic imaging agents
AU3419584A (en) Mud-conditioning agent
AU577781B2 (en) Lung imaging with radiolabelled agents
AU568050B2 (en) Microsphere-polymer blends
AU565345B2 (en) Polyetherimide-polypropylene blends
GB8318216D0 (en) Floor construction
AU558223B2 (en) Tube construction kit
GB2142406B (en) Connection
EP0145328A3 (en) Substituted tetrazolinones
AU570437B2 (en) g
AU536396B3 (en) Diagnostic aid
GB8327548D0 (en) Floor construction
AU557479B2 (en) Ball